Marc Wiesenberger
Stock Analyst at B. Riley Securities
(3.02)
# 1,431
Out of 5,002 analysts
32
Total ratings
62.96%
Success rate
52.03%
Average return
Main Sectors:
Stocks Rated by Marc Wiesenberger
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SMLR Semler Scientific | Downgrades: Neutral | $60 → $45 | $31.36 | +43.49% | 7 | Nov 2, 2022 | |
OPRX OptimizeRx | Maintains: Buy | $71 → $56 | $17.60 | +218.18% | 1 | Jul 20, 2022 | |
CLPT ClearPoint Neuro | Reinstates: Buy | $15 | $25.05 | -40.12% | 2 | Apr 5, 2022 | |
OESX Orion Energy Systems | Downgrades: Neutral | $85 → $50 | $8.23 | +507.53% | 5 | Nov 10, 2021 | |
ZYXI Zynex | Upgrades: Buy | $18 | $1.45 | +1,122.76% | 9 | Jul 16, 2021 | |
NSIT Insight Enterprises | Maintains: Buy | $67 → $64 | $112.00 | -43.30% | 3 | May 11, 2020 | |
LPTH LightPath Technologies | Maintains: Buy | $2.1 → $3.25 | $8.17 | -60.22% | 5 | May 8, 2020 |
Semler Scientific
Nov 2, 2022
Downgrades: Neutral
Price Target: $60 → $45
Current: $31.36
Upside: +43.49%
OptimizeRx
Jul 20, 2022
Maintains: Buy
Price Target: $71 → $56
Current: $17.60
Upside: +218.18%
ClearPoint Neuro
Apr 5, 2022
Reinstates: Buy
Price Target: $15
Current: $25.05
Upside: -40.12%
Orion Energy Systems
Nov 10, 2021
Downgrades: Neutral
Price Target: $85 → $50
Current: $8.23
Upside: +507.53%
Zynex
Jul 16, 2021
Upgrades: Buy
Price Target: $18
Current: $1.45
Upside: +1,122.76%
Insight Enterprises
May 11, 2020
Maintains: Buy
Price Target: $67 → $64
Current: $112.00
Upside: -43.30%
LightPath Technologies
May 8, 2020
Maintains: Buy
Price Target: $2.1 → $3.25
Current: $8.17
Upside: -60.22%